ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1362	National Cancer Institute	Html	en	Hot Flashes and Night Sweats (PDQ®)–Health Professional Version	Expert-reviewed information summary about causes and treatment of hot flashes and night sweats in cancer patients.	hot flash scores 0.45918 tamoxifen-induced hot flashes 0.487401 Loprinzi CL 0.545839 menopausal symptoms 0.464059 Barton DL 0.475444 nocturnal hot flashes 0.494473 black cohosh 0.488248 androgen deprivation therapy 0.448869 clinical trial 0.448391 breast cancer treatment 0.460098 breast cancer patients 0.474226 postmenopausal breast cancer 0.456276 hot flashes merits 0.487946 Natl Cancer Inst 0.459556 breast cancer survivors 0.509665 North Central Cancer 0.472407 hot flash reduction 0.458714 hot flashes 0.905213 hormone replacement therapy 0.476539 et al. 0.506432 women 0.50642 core body temperature 0.45737 night sweats 0.457026 study 0.456946 stage breast cancer 0.454333	hot flash studies 0.449594 hot flushes 0.465978 breast cancer diagnosis 0.451556 postmenopausal hot flashes 0.500892 breast cancer recurrence 0.47207 hot flash management. 0.448239 PUBMED Abstract 0.549613 Cancer Res Treat 0.462211 nighttime hot flashes 0.501942 hot flash frequency 0.50736 menopausal hot flashes 0.487616 Cancer Treatment Group 0.476248 hot flash management 0.49365 postmenopausal women 0.477394 breast cancer risk 0.486953 Clin Oncol 0.505954 receptor–positive breast cancer 0.451466 breast cancer 0.743246 randomized controlled trial 0.545918 hot flash 0.591793 healthy postmenopausal women 0.454945 prostate cancer 0.455636 placebo-controlled trial 0.450402 Central Cancer Treatment 0.476295	CLICK HERE
1452	National Cancer Institute	Html	en	Cigarette Smoking: Health Risks and How to Quit (PDQ®)–Health Professional Version	Expert-reviewed information summary about research and guidelines focused on the prevention and cessation of cigarette smoking.	smoking cessation strategy 0.633721 smoking cessation rates 0.605741 quit attempt 0.552085 effective smoking cessation 0.580922 gradual cessation group 0.483049 abrupt cessation 0.562882 prolonged validated smoking 0.480554 lung cancer 0.658405 tobacco cessation 0.463262 smoking cessation pharmacotherapies 0.597527 abrupt smoking cessation 0.601297 pipe tobacco smoking 0.505275 current smoking 0.475722 gradual cessation arm 0.465437 nicotine replacement therapy 0.54532 randomized trial 0.492165 Smoking cessation counseling 0.609156 receptor partial agonist 0.460896 area-level smoking prevalence 0.513667 smoking reduction 0.49426 smoking behavior 0.469981 smoking cessation treatment 0.588411 smoking prevalence data 0.513642 tobacco products 0.485537	abrupt cessation arm 0.472163 smoking cessation 0.926558 vs abrupt cessation 0.475821 adult cigarette smoking 0.474818 gradual cessation method 0.466403 cigarette smoking cessation 0.573293 cigarette smoking 0.62168 smoking cessation pharmacotherapy 0.595082 varenicline 0.542592 tobacco smoking 0.505702 smoking cessation rate. 0.602815 gradual cessation 0.501212 abrupt cessation group 0.489713 nicotinic acetylcholine receptor 0.464069 self-reported smoking abstinence 0.502629 smoking abstinence 0.574891 cigarette smoking prevalence 0.566333 randomized controlled trial 0.482431 6-month cessation rates 0.474432 nicotine patch 0.531368 smoking cessation intervention 0.590903 usual smoking patterns 0.480697 lung cancer mortality 0.510576 varenicline group 0.534998	CLICK HERE
1610	National Cancer Institute	Html	en	Myelodysplastic/ Myeloproliferative Neoplasms Treatment (PDQ®)–Health Professional Version	Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are composed of three major myeloid disorders: chronic myelomonocytic leukemia (CMML), juvenile myelomonocytic leukemia (JMML), and atypical chronic myeloid leukemia (aCML). Learn about the clinical features and treatment of these leukemias.	JMML 0.47142 5-year estimated probability 0.444988 evidence 0.458611 host disease grade 0.440441 anemia supervenes 0.445725 various chemotherapy regimens 0.572089 platelet-derived growth factor 0.511436 Leukemia Group 0.448642 white blood cells 0.44993 Myelodysplastic/ Myeloproliferative Neoplasms 0.440718 CMML 0.717566 marrow stem cell 0.463204 myelomonocytic leukemia 0.462437 HLA-matched unrelated individuals 0.444789 toxic effects 0.442066 bone marrow aplasia 0.560704 chronic myelomonocytic leukemia 0.449424 transplant-related mortality 0.457149 World Health Organization 0.564993 erythropoietic growth factors 0.554859 median age 0.543021 level 0.460994 randomized trial 0.458448 patients 0.901262 monthly maintenance 0.44579	randomized clinical trial 0.484352 major defining feature 0.454521 complete remission 0.448646 proliferative features 0.448887 DNA methyltransferase 0.449167 et al. 0.534469 young MDS patients 0.511634 follow-up study 0.441281 Complete hematologic remissions 0.570636 JMML leukemia cells 0.462656 pyrimidine-analog antimetabolite 0.44631 stem cell 0.531211 single-agent therapy 0.444312 13-cis retinoic acid 0.524469 transfusion requirements 0.448178 Median actuarial survival 0.504944 median duration 0.676959 nucleoside azacitidine 0.478539 particularly poor prognosis. 0.444869 patient survival data. 0.445943 bone marrow 0.729115 total-body radiation therapy 0.553338 allogeneic stem cell 0.441128 Juvenile myelomonocytic leukemia 0.458499	CLICK HERE
1682	National Cancer Institute	Html	en	Family Caregivers in Cancer: Roles and Challenges (PDQ®)–Health Professional Version	Expert-reviewed information summary about the challenges faced by family caregivers of cancer patients. This summary focuses on typical caregiver roles and concerns, and helpful interventions for caregivers.	caregiver strain 0.637562 caregiver self-efficacy 0.583778 caregiver involvement 0.610915 cancer care facility 0.578352 palliative care consultation 0.608288 caregiver knowledge 0.586068 Hispanic caregivers 0.676204 caregiver 0.821035 Caregiver quality 0.603509 white caregivers 0.639176 health care providers 0.59721 specialist-level palliative care 0.56948 caregiver well-being 0.592799 patient symptom care 0.583377 culturally competent care 0.564531 patients 0.715455 cancer patients 0.703941 Asian American caregivers 0.689382 caregiver emotional health 0.625075 secondary informal caregivers 0.653486 caregiver burden 0.63516 caregiver’s information 0.595277 symptom management 0.696609 orient caregivers 0.633121 primary caregiver 0.613245	caregiver portion 0.581896 African American caregivers 0.664952 caregiver needs 0.592313 end-of-life care 0.586635 family caregivers 0.726566 study 0.578902 problem-solving intervention 0.564815 bereaved caregivers 0.642182 palliative care 0.6279 tailored caregiver interventions. 0.613747 African American patients 0.595756 caregivers 0.977146 terminally ill patients 0.564522 studies 0.568233 empowers caregivers 0.628512 caregiver roles 0.620453 minority caregivers 0.663649 emotional support 0.572233 home care workers 0.567134 Caregivers report 0.630818 Caregiver assessment 0.592589 family caregiver 0.60516 cancer patient 0.576832 difficult caregiver responsibilities 0.601191	CLICK HERE
1790	National Cancer Institute	Html	es	Trastornos del sueño (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca de las causas y manejo de los trastornos del sueño en las personas con cáncer.	menudo causa problemas 0.738807 TCC ayuda 0.533662 pequeño número 0.542064 siguientes aspectos 0.690699 siguientes elementos 0.547894 leucemia linfocítica aguda 0.539982 sudores nocturnos 0.6269 siguientes cambios 0.544948 menor número 0.522208 Frecuencia respiratoria 0.534403 fase monr 0.549571 salud afectarán 0.52618 National Cancer Institute 0.522679	sueño mejora 0.68532 siguientes riesgos 0.520223 sueño mor 0.930755 Instituto Nacional 0.543079 siguientes problemas 0.588617 siguientes funciones 0.571878 Physician Data Query 0.591028 fase mor 0.552867 PDQ Trastornos 0.547079 auto hipnosis 0.530427 numerosas razones 0.546303 solo relajarme 0.534672	CLICK HERE
1927	National Cancer Institute	Html	es	Tratamiento del linfoma de Hodgkin infantil (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del linfoma de Hodgkin infantil.	siguientes procedimientos 0.539535 células madre 0.949818 estadio iv 0.500925 adultos jóvenes 0.452563 órgano cercano.ampliar linfoma 0.561365 siguientes elementos 0.448931 sudores nocturnos 0.484622 faja ajustadora 0.430459 siguientes especialistas 0.43177 siguientes tipos 0.443725 vía oral 0.419326 rayos x 0.473568 Hodgkin Lymphoma 0.582459 abdomen).ampliar linfoma 0.535694 detecte.ampliar exploración 0.434601 enlace drugs approved 0.498183 escáner tep 0.492453 niño ayuda 0.424524 estadio iiies 0.760474 riesgo intermedio 0.462626 efectos tardíos 0.664689 estadio ie 0.575058 células anormales.ampliar aspiración 0.485872	PDQ Efectos tardíos 0.461638 National Cancer Institute 0.420283 sustancia quizás 0.427861 siguientes lugares 0.433237 siguientes riesgos 0.418851 Instituto Nacional 0.434896 PDQ Tratamiento 0.682769 estadio iie 0.500587 Hodgkin recién 0.557678 explorador tep 0.443167 estadio e 0.45134 nuevos tipos 0.421275 Physician Data Query 0.471298 posibles efectos 0.420063 infancia quizás 0.428464 estadio iiis 0.959473 ósea fabrica glóbulos 0.493208 pelvis.ampliar imágenes 0.420331 distinta intensidad 0.419212 almacena células 0.485736 siguientes pruebas 0.485604 siguientes estadios 0.440037	CLICK HERE
2105	National Cancer Institute	Html	es	Exámenes de detección del cáncer de endometrio (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de endometrio.	Surgical Adjuvant Breast 0.318516 Obstet Gynecol 0.462808 endometrial neoplasia 0.330318 endometrial carcinoma 0.35462 mujeres asintomáticas conducirán 0.327753 endometrial biopsy 0.375747 Society Cancer Detection 0.324775 Sin embargo 0.322994 American Cancer Society 0.532275 Barakat RR 0.322448 postmenopausal estrogen 0.311047 Hereditary nonpolyposis colon 0.316803 Cancer Society Guidelines 0.326353 mutation analysis 0.309345 CA Cancer 0.344524 ecografía transvaginal 0.32543 Instituto Nacional 0.316776 PDQ Exámenes 0.310268 Natl Cancer Inst 0.409601 Vasen HF 0.314679 Bowel Project P-1 0.314149 Survival analysis 0.309166 endometrial thickness 0.328405 Gynecol Oncol 0.319248 patients with 0.312917	endometrial cancer 0.986652 Endometrial morphology 0.328059 Genetics Studies Consortium 0.313592 Cancer Facts 0.328027 Cancer risk 0.385512 with endometrial biopsy 0.334209 mutation carriers 0.308983 Cancer Survival Study 0.330775 hereditary nonpolyposis 0.373835 National Cancer Institute 0.323419 endometrial biopsy specimens 0.329768 replacement therapy 0.315579 postmenopausal women 0.352328 Clin Oncol 0.321066 Gynaecol Obstet 0.310774 PDQ Genetics 0.309874 mujeres portadoras 0.322212 adjuvant breast 0.320298 ecografía endovaginal 0.333573 endometrial abnormalities 0.37706 National Surgical Adjuvant 0.314342 Ultrasound Obstet Gynecol 0.310185 mujeres morirán 0.321645 Mecklin JP 0.317214	CLICK HERE
2114	National Cancer Institute	Html	es	Exámenes de detección del cáncer de hígado (hepatocelular) (PDQ®)–Versión para pacientes	Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de hígado (hepatocelular).	hepatitis c 0.799278 PDQ Exámenes 0.723065 estudio marcadores 0.652784 siguientes efectos 0.659695 Physician Data Query 0.826748 Estados Unidos 0.932003 rayos x 0.659043 prevención revisa 0.639071 sustancias dañinas 0.671115	cuerpo usa 0.666699 ondas sonoras 0.6623 siguientes exámenes 0.740755 información ayuda 0.645281 National Cancer Institute 0.657644 siguientes riesgos 0.650336 siguientes sumarios 0.743208 Instituto Nacional 0.706872 múltiples funciones 0.667669	CLICK HERE
3523	National Cancer Institute	Html	es	Estudio NCI-MATCH (Análisis Molecular para Selección de Tratamientos)	Información sobre el estudio del NCI: Análisis Molecular para Selección de Tratamientos (NCI-MATCH), en el cual los investigadores examinarán tejidos de tumor de pacientes con tumores sólidos y linfomas avanzados que han dejado de responder al tratamiento.	Tumor Profiling 0.554625 estudio match 0.941659 Investigación Oncológica 0.6022 MD Anderson 0.61416 Memorial Sloan-Kettering Cancer 0.578519 Clinical Trials 0.539697 posibles participantes 0.607033 C2 MET 0.546519 Life Sciences 0.627896 laboratorios foundation medicine 0.56991 Foundation Medicine 0.623082 Memorial Sloan-Kettering identificarán 0.577406 estudio comet 0.807536 Grupo Cambio 0.537516 met amp crizotinib 0.576245	como los costos 0.539059 seguro médico 0.533808 Cancer Center 0.605302 MD Anderson Cancer 0.572606 tratamiento inscribirán 0.618222 sk crizotinib 0.541473 cabo estudios 0.534561 Caris Life Sciences 0.579205 Investigación Oncológica ECOG-ACRIN 0.571301 Memorial Sloan-Kettering 0.625566 egfr mut afatinib 0.573282 NRG Oncology Group 0.568484 Iniciativa de Medicina 0.538366 Life Sciences identificarán 0.57351	CLICK HERE
15802	National Cancer Institute	Html	null	About the Blue Ribbon Panel	Information about the Cancer Moonshot Blue Ribbon Panel of experts. The panel was established to ensure the Cancer Moonshot's goals and approaches are grounded in the best science.			CLICK HERE